A 29-year-old woman sustained an acute massive pulmonary embolism in the 32nd week of pregnancy. Rapid clinical improvement followed the use of streptokinase. Treatment was continued for 41 hours, including labour and the first three hours after delivery. There was slow but severe postpartum haemorrhage. Partial uterine atony occurred, and may have been due, at least in part, to fibrin degradation products arising from thrombolysis. No adverse effects were noted in the baby.
Introduction
Thrombolytic therapy has been used in the last two decades to treat a variety of thrombotic and thromboembolic conditions. Renewed interest in thrombolytic therapy has resulted from the development of thrombolytic agents of greater purity. One such agent, streptokinase, usually produces rapid resolution of pulmonary embolism (Hirsh et al., 1968; Miller et al., 1969) . Such resolution assessed by pulmonary arteriography is significantly greater after treatment with streptokinase than with heparin over a 72-hour period as shown by pulmonary arteriography (Miller et al., 1971) . Pregnancy and recent surgery may both predispose to venous thrombosis and pulmonary embolism, and indeed thromboembolism is now the second most common cause of maternal mortality (Department of Health and Social Security, 1969) . A fatal thromboembolic episode occurs once in every 25,000 pregnancies (Ministry of Health, 1969) and, although the incidence of non-fatal thromboembolism is less easily established, a figure of 3 3 per thousand pregnancies has been reported (Jeffcoate and Tindall, 1965) .
A case of massive pulmonary embolism occurring during pregnancy and treated with streptokinase is reported. The management is discussed with particular reference to the complications of thrombolytic therapy.
Case History A 29-year-old woman was admitted to hospital in the 32nd week of her second pregnancy for excision of a suspected malignant melanoma on her left calf. The next day the lesion was widely excised and skin-grafting was performed. Histological examination of the lesion showed it to be a benign lentigo. She was confined to bed for six days postoperatively. (Miller et al., 1969 (Miller and Sutton, 1970) (Hirsh et al., 1968) .
Thrombolytic therapy with comparable doses of streptokinase given during pregnancy has been reported by Ludwig (22 cases) and Pfeiffer (15 cases) (Ludwig, 1968; Pfeiffer, 1970 Animal experiments (Ludwig, 1966) with unlabelled streptokinase show that depending on the species between 0 1 and 1% of doses in the therapeutic range cross the placenta.
In the case described here there was no exteral evidence of haemorrhage in the baby at birth. The baby had a euglobulin lysis time of 9 5 min (normal range in cord blood 10-330mi. (Ekelund et al., 1970) ), normal fibrinogen levels, and a slightly prolonged prothrombin time. The placental histology was normal. These data suggest tbat after 40 hours of treatment with streptokinase the fetus was not adversely affected.
The greatest problem was a slow but persistent postpartum haemorrhage. This was associated with failure of the uterus to remain firmly contracted despite large doses of oxytocic agents. Haemostasis at the placental site is generally thought to be mechanical, and women with severe thrombocytopenia or receiving anticoagulant treatment may be delivered without excessive blood loss providing uterine atony does not occur (Basu, 1969) . During thrombolysis fibrin is broken down into a series of degradation products which are released into the circulation. These may cause a variety of haemostatic defects which cannot be reversed by anti-fibrinolytic agents such as aminocaproic acid or aprotinin. Fibrin degradation products have been shown to inhibit myometrial contractility in vitro. This may be due both to interference with ionic transport across the myometrial cell membrane (Malofiewjew et al., 1971 ) and local inhibition of kininases (Hamberg, 1969) . The latter are responsible for the breakdown of pharmacologically active amines such as bradykinin, and if these are allowed to accumulate locally they may inhibit uterine contraction (Landesman et al., 1963) .
In the present patient the levels of fibrin degradation products were assayed only at delivery, when they were at the upper limit of normal (0-96 Fg/ml). It is possible that they were higher at other times during treatment and may have been responsible, at least in part, for the discontinuance of established labour 12 hours after the onset of streptokinase therapy, and also for the uterine atony which occurred postpartum. The reason for rupturing the membranes and expediting delivery once this appeared inevitable was the fear of placental separation during labour. If the inhibitory effects of either plasmin acting as a possible oxytocinase or fibrin degradation products as described above had been expected we might not have interfered. The postpartum haemorrhage was controlled by stopping treatment with streptokinase, administering aminocaproic acid to reverse fibrinolysis, and using continuous fundal massage to maintain uterine contraction after large doses of oxytocic agents alone had failed. Stopping of the haemorrhage may have resulted from any of these measures, but we regard the fundal massage as important.
Aminocaproic acid was used here to reverse fibrinolysis five hours after delivery. It is a small molecule readily crossing the placental barrier, and should not therefore be used during pregnancy when aprotinin (Trasylol), which has a larger molecule and does not readily cross the placenta, is to be preferred (Pfeiffer, 1970) . In addition, a correlation has been found in premature babies between low levels of endogenous fibrinolytic activity and the occurrence of the respiratory distress syndrome (Makarin et al., 1967) . The use of aminocaproic acid near term might therefore, at least theoretically, predispose to this syndrome in the infant.
As a result of our experience with the present patient, certain factors relating to the use of streptokinase in pregnancy and particularly during labour have emerged: (1) labour continues satisfactorily during treatment with streptokinase if oxytocic agents are used; (2) in order to prevent serious postpartum haemorrhage consideration should be given to stopping streptokinase four to six hours (which is the half life of fibrin degradation products) before delivery is expected; (3) continuous massage of the fundus, postpartum, is recommended to prevent uterine relaxation; and (4) if reversal of fibrinolysis is required before delivery, aprotinin rather than aminocaproic acid should be used.
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Paroxysmal nocturnal haemoglobinuria is diagnosed on the basis of a positive acidified serum lysis test. An association between the disease and aplastic anaemia is well established (Lewis and Dacie, 1967) . The development of a paroxysmal nocturnal haemoglobinuria-like abnormality-that is, a positive acidified serum lysis test-has been seen in myelosclerosis (Lewis et al., 1971) and, conversely, acute myeloblastic leukaemia has developed in at least six patients with pre-existing paroxysmal noctumal haemoglobinuria. The patient reported here developed a positive acidified serum test during the course of a lymphoproliferative malignant disease. He had a concomitant autoimmune haemolytic anaemia and hypogammaglobulinaemia.
Case Report A caucasian man, aged 59 years was admitted to Hammersmith Hospital in April 1969 with a six-week history of lymph node enlargement, sweating, and weight loss. On clinical examination he was apyrexial, not jaundiced, and had no petechiae or bruising. Large (2-4 cm) very firm anterior and posterior cervical nodes, and palpable auricular, submandibular, and submental nodes were present. There was a 20-cm splenomegaly and 6-cm hepatomegaly. Occasional haemorrhages were present in both fundi. The blood count gave the following results: haemoglobin 8-4 g/100 ml, reticulocytes 0-8%, platelets 107,000/mm3, W.B.C. 370,000/mm3 with 82% lymphocytes. The lymphocytes were predominantly small mature cells, but about 15% were larger nucleolated lymphoid cells showing varying degrees of immaturity. A direct antiglobulin test was strongly positive (IgG). The bone marrow was markedly hypercellular and infiltrated with predominantly small mature numbers comparable to those found in the peripheral blood. Uric acid was 9 1 mg/ml, bilirubin 0 4 mg/100 ml, alkaline phosphatase 19 K.A. units, serum albumin was 3-5 g/100 ml, and globulin was 2-1 g/100 ml. Immunoglobulins were: IgG 820, IgA 85, and IgM less than 10 mg/100 ml. No serum myeloma-like protein was present. However, Bence Jones protein, type k, was detected in a concentration of 4 mg/ 100 ml. A 51Cr red cell survival study was normal (Tso 24 days). A chest x-ray film showed bilateral hilar lymphadenopathy, confirmed by tomography. A diagnosis of chronic lymphocytic leukemia was made, although the atypical blood and bone marrow morphology and strikingly firm lymphadenopathy on palpation raised the possibility of this being a variant of lymphocytic lymphoma.
The patient was treated with chlorambucil, 5 mg/day, allopurinol 400 mg/day, and prednisone 40 mg/day. He was discharged 16 days after admission on prednisone 40 mg/day and allopurinol 300 mg/day. He was then symptom-free and the lymphadenopathy was greatly reduced. The evolution of the disease is shown in the chart.
Between May and August 1969 he became progressively anaemic with increasing anorexia, fever, and sweats, despite receiving chlorambucil and prednisone. He was readmitted to hospital in August. Examination showed splenomegaly (6 cm), hepatomegaly (7 cm), and multiple very firm axillary, cervical, and inguinal nodes. Haemoglobin was 5-8 g/ 100 ml, reticulocytes were 22%, platelets were 88,000/mm3, and W.B.C. was 9,000/mm3 with 87% lymphocytes. The peripheral blood film showed spherocytes, polychromasia, and anisocytosis. A direct antiglobulin test was again strongly positive (IgG). In an auto-red cell survival study the 51Cr T5o was eight days, and surface counting showed that the spleen was the principal site of red cell destruction. As the acute haemolysis did not respond to high doses of prednisone, splenectomy was performed. The spleen weighed 980 g; its sinuses were packed with red cells and widened splenic cords contained many lymphocytes, some mature and some poorly differentiated. Sections of a superficial lymph node removed at the time of surgery showed that the normal cellular architecture had been completely replaced by a uniform mass of rather poorly differentiated lymphocytes. Splenectomy was followed by a rapid improvement in the blood count. and the patient was discharged in October on prednisone, 5 mg/day (see chart). Haemoglobin was 115 g/100 ml, reticulocytes were 1-8%, W.B.C. was 16,000/mm3, and platelets were 454,000/mm3. A red cell survival study performed one month later was normal (T50 25 days). From February to June 1971 superficial lymph nodes showed progressive enlargement despite continuing chemotherapy. In June of that year a five-week course of local radiotherapy was given to enlarging cervical and inguinal nodes, with subsequent shrinkage of the tumour masses. In August an inguinal node was also irradiated. From then until November the patient showed continuing clinical deterioration without evidence of further superficial node enlargement. On his final admission in November he was sick, wasted, and pyrexial. The superficial nodes were not enlarged above 1-5 cm. A lymphangiogram, however, showed the presence of large abnormal para-aortic glands, and a chest radiograph showed the recurrence of bilateral hilar lymphadenopathy. Accordingly he was started on a course of radiotherapy to the para-aortic region (see
